Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 1
An Unusual Malignant Spindle Cell Lesion to Involve the Breast
Erinn Downs-Kelly, D.O.Associate Professor of PathologyUniversity of Utah & ARUP Laboratories
• No disclosures
Case
• 39 y/o female with no significant past medical history presented with a 1.5 cm palpable, self discovered left breast mass
– Admits lesion has been present for at least a year
• Imaging including mammography and ultrasound showed irregular shape, spiculated margins, and posterior acoustic shadowing
• Initial ultrasound guided core needle biopsy performed elsewhere showed the following:
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 2
Initial core needle biopsy
CK AE1/AE3
Impressions from the core needle biopsy
• Cellular malignant spindle cell neoplasm with focal cytokeratin AE1/3 immunoreactivity
• Negative for expression of myoepithelial, muscle specific, neural or melanocytic, vascular and myofibroblastic markers
• Metaplastic carcinoma???
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 3
Malignant spindle cell lesions of the breast
• Metaplastic carcinoma
– Low grade fibromatosis-like spindle cell carcinoma
– Spindle cell type (sarcomatoid carcinoma)
– Myoepithelial carcinoma
• Primary sarcomas of the breast
• Stromal component of a malignant phyllodes tumor
• Metastatic lesions– Malignant melanoma
– Sarcomas
– Poorly differentiated carcinoma
• 2012 WHO Classification of Tumours of the Breast
• Characterized by differentiation of neoplastic epithelium into squamous cells and/or mesenchymal appearing components
– Spindle, chondroid, osseous and rhabdomyoid
– Purely composed of metaplastic elements or admixture of identifiable carcinomatous component an metaplastic elements
• Low-grade (fibromatosis-like) spindle cell carcinoma
• Spindle cell carcinoma (sarcomatoidcarcinoma)
• Metaplastic carcinoma with osteoclastic giant cells
• Squamous cell carcinoma
• Low grade adenosquamous carcinoma
• Carcinoma with mesenchymal differentiation
– Chondroid
– Osseous
– Other mesenchymal differentiation
• Myoepithelial carcinoma
Metaplastic carcinoma
Metaplastic carcinoma
• Account for
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 4
Hypocellular spindle cell lesion with short fascicles and admixed dense collagen bundles
Adjacent lymphoid aggregate
Low-grade fibromatosis-like spindle cell carcinoma
Overall bland cytology of the spindle cells without mitotic activity
Low-grade fibromatosis-like spindle cell carcinoma
Cytokeratin positive- broad panel
p63 positive
Nuclear β catenin+/-
Low-grade fibromatosis-like spindle cell carcinoma
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 5
Spindle cell carcinoma (Sarcomatoid carcinoma)
• Microscopic findings
– Atypical spindle cells arranged in varied patterns
• Fascicles with a herringbone appearance or storiform
• Nuclear pleomorphism is usually moderate to high
• Frequent mitotic figures
• May entrap breast epithelium at the leading edge
Carter et al. Am J Surg Pathol. 2006; 30:300-309Davis et al. Am J Surg Pathol. 2005;29:1456-1463
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 6
Spindle cell carcinoma
Focal area of glandular differentiation
Metaplastic carcinoma: IHC pitfall
• When first evaluated in metaplastic carcinoma and phyllodes, p63 appeared sensitive and highly specific for metaplastic carcinoma
– Koker et al: 189 invasive breast carcinomas (15 metaplastic carcinomas, 10 phyllodes tumors and 5 sarcomas of the breast)
– p63 was strongly expressed in 13 of 15 metaplastic carcinomas (86.7%); phyllodes tumors and sarcomas were negative for p63 expression
– Sensitivity and specificity of 86.7% and 99.4%, respectively
• More recently, Cimino-Mathews et al identified expression of focal p63, p40, and cytokeratin (AE1/AE3, Cam5.2, 34βE12) in malignant PT but not in borderline or benign PT
Koker MM and Kleer, CG. Am J Surg Pathol. 2004 Nov;28(11):1506-12.Cimino-Mathews, A. et al. Am J Surg Pathol 2014;38:1689–1696.
Primary Sarcoma of the Breast
• Before diagnosing a primary sarcoma of the breast, consider and exclude
– Metaplastic carcinoma: IHC and extensive tumor sampling to exclude in situ or invasive carcinoma
– Heterologous sarcomatous elements in phyllodes tumor (PT) can be prominent and the epithelial components can be relatively inconspicuous
– Metastasis?
• Primary sarcomas
– Arise from interlobular mesenchymal elements
– Subclassified according to their growth patterns and histiogenesis
– Most common primary sarcoma of the breast is angiosarcoma, followed by liposarcoma, leiomyosarcoma, pleomorphic undifferentiated sarcoma
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 7
Primary sarcoma
• Very rare, SEER data reports the annual incidence as 4.6 cases per 1,000,000 women
• Previous history of radiation increases the risk for development of angiosarcoma and pleomorphic undifferentiated sarcoma
• Complete excision is crucial for treatment
– Presence of residual disease after initial treatment had a 10 year probability of local control and of disease free survival of 0%
Metastases Involving Breast
• Clinical history is key
• Most common entities to metastasize to the breast:
– Malignant melanoma
– Lung and ovary
• Breast metastasis may be the first sign of malignancy in roughly 30% of cases
• Propensity for rhabdomyosarcoma, in adolescents, to metastasize to breast
21
2.5 cm breast mass in 15 year old female with no past medical history
MyogeninCourtesy of Dr. David Hicks
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 8
3 cm breast mass in a 58 year old female with a history of metastatic leiomyosarcoma to the lung
H-caldesmon
Back to our case
Lumpectomy and Sentinel Lymph Node Biopsy
• 1.5 cm ill defined mass with marker clip
– Mass and surrounding tissue entirely submitted
• > 1 cm to all margins
• Two sentinel lymph nodes negative for malignancy
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 9
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 10
Not Adding Up
• No recognizable in situ or conventional invasive epithelial component– Entrapped benign epithelium at the leading edge
– Some spindle cell carcinomas may be purely spindled
• Lesion had been present for at least a year
• Imaging was not “characteristic” of a metaplastic carcinoma
• Cytomorphology is uniform
• IHC: p63 (-)
FISH for SS18 RearrangementSS18 (18q11) – Break-Apart Probe
Normal fused SS18 signal
Rearranged SS18 signal
Synovial Sarcoma (SS)• SS account for roughly 10% of all soft tissue sarcomas
– t(X;18;p11;q11) translocation
– SS18-SSX1, SS18-SSX2, SS18-SSX4
• Typically arise in the para-articular regions in adolescents and young adults
– Less commonly arise in the trunk, abdomen, head and neck
• Histologic variety: biphasic, monophasic and poorly differentiated
– Biphasic tumors contain both epithelioid cells arranged in glandular structures and spindle cells
– Monophasic types are entirely composed of spindle cells
– Poorly differentiated usually have a large epithelioid cell appearance
• Small cell variant and a high-grade spindle cell variant
57th Annual HSCP Spring Symposium 4/16/2016
Erinn Downs‐Kelly, DO 11
Synovial Sarcoma (SS)
• Cytokeratin 7, 8/18, 19 (expressed in spindled and epithelioid components)
• AE1/AE3 (expressed in spindled and epithelioid components)
• EMA (expressed in spindled and epithelioid components)
• CEA, bcl-2 (expressed in spindled and epithelioid components)
• TLE1 (97%)
Synovial Sarcoma of the Breast
• Primary SS:
– Rare case reports supported by either evidence of SS18 rearrangement or evidence of the fusion transcripts SS18-SSX1 or SS18-SSX2
• Metastatic SS to breast:
– Rare case reports with the identification of SS in the breast leading to the identification of the primary (lung) and extremity
Tormo V, et al Clin Transl Oncol 2009 Dec;11(12):854-5Doyle VJ, et al BMJ Case Rep 2013 Jun 19;2013Sobande F, et al Breast J. 2011 Jul-Aug;17(4):418-9Kijima Y, et al Surg Today 2007;37(3):230-3
Follow up for Our Patient• Synovial Sarcoma, Monophasic
– pT1a
– FNCLCC grade 2
– SS18-SSX2 transcript and SS18 rearrangement identified
• Work up to exclude the possibility that this was a metastasis
– Staging with PET/CT
• 1.9 years status post resection with widely negative margins
– No evidence of distant metastatic disease
• NCCN Sarcoma Guidelines